Biological versus mechanical heart valve prosthesis during pregnancy in women with congenital heart disease

Heleen Lameijer, Ymkje J. van Slooten, Monique R. M. Jongbloed, Martijn A. Oudijk, Marlies A. M. Kampman, Arie P. van Dijk, Marco C. Post, Barbara J. Mulder, Krystyna M. Sollie, Dirk J. van Veldhuisen, Tjark Ebels, Joost P. van Melle, Petronella G. Pieper*

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

8 Citaten (Scopus)

Samenvatting

Background: We evaluate pregnancy outcome and anticoagulation regimes in women with mechanical and biological prosthetic heart valves (PHV) for congenital heart disease.

Methods: Retrospective multicenter cohort studying pregnancy outcomes in an existing cohort of patients with PHV.

Results: 52 women had 102 pregnancies of which 78 pregnancies (46 women) >= 20 weeks duration (59 biological, 19 mechanical PHV). Miscarriages (n = 19,

Conclusion: Complications occur more often in pregnancies of women with a mechanical PHV than in women with a biological PHV, mainly caused by PHV thrombosis and bleeding complications. Meticulous monitoring of anticoagulation in pregnant women is necessary. Women with a pulmonary mechanical PHV are at high risk of complications. (C) 2018 Published by Elsevier B.V.

Originele taal-2English
Pagina's (van-tot)106-112
Aantal pagina's7
TijdschriftInternational Journal of Cardiology
Volume268
DOI's
StatusPublished - 1-okt-2018

Citeer dit